Global Peptic Ulcer Testing Market Research and Analysis 2015-2022
Market Insights
Global Peptic Ulcer Testing market is projected to witness a significant growth rate during the forecasted period 2017-2022. The growth of the market is backed by the increasing incidences of stomach cancer coupled with the changing lifestyle & food habits such as untimely meal patterns, excess consumption of fatty foods, chronic acidity and food poisoning. As per American Cancer Society, around 28,000 cases of stomach cancer is estimated to be diagnosed in the U.S. in 2017, up from 26,370 cases in 2016 and about 10,960 individuals are projected to die due to it. Such scenario has raised the need for faster as well as accurate diagnosis of peptic ulcer. The most commonly occurring stomach disease called peptic ulcer is primarily caused by sores and lesions owing to the excess secretion of the hydrochloric acid as well as pepsin enzyme from the histamine cells into the gastrointestinal tract. This disease generally occurs owing to the H. pylori (Helicobacter pylori) bacterium but can also be caused by long term usage of the non-steroidal anti-inflammatory drugs. Whereas in rare cases peptic ulcer can also occur due to presence of some specific illness or inheritance. However, only 10-15% of Helicobacter pylori positive cases develop peptic ulcers but up to 90% of all peptic ulcers occur owing to H. pylori.
In developing and underdeveloped countries, the prevalence of peptic ulcers is greater than in developed countries. This fact is further supported by the presence of high population within developing countries which is directly attributing towards the growth of the global peptic ulcer testing market. The other key factors that are driving the growth of the global market are growing usage of rapid urease test for h. pylori detection and development of advanced & new testing techniques. However, medical reimbursement issues related to certain tests in some countries is currently hampering the growth of the global peptic ulcer testing market.
Geographical Insights
Global Peptic Ulcer Testing market can be segmented geographically into Europe, North America, Asia Pacific and RoW. In 2016, Asia Pacific held the largest market in terms of rapid tests for H. pylori across the globe. Whereas in terms of revenue generation, North America leads the global peptic ulcer testing market owing to the rise in number of people suffering from peptic ulcer. In the U.S., around 5 million individuals are affected by peptic ulcer at any given time. Peptic ulcer is an important cause of the morbidity as well as healthcare costs; estimates of expenditures related to hospitalization, work loss and outpatient care (excluding medication costs) totaled around $5.65 billion per year in the U.S. Whereas, Asia Pacific is expected to witness the highest growth rate during the forecasted period. In Asia Pacific region, the incidence of peptic ulcer disease is quite high as most countries within this region are developing or under-developed and have relatively poor sanitation & hygienic condition which results in rise to contracting H. pylori infections. As per WHO, peptic ulcer disease deaths reached 85,487 in India in 2014. The age adjusted death rate due to peptic ulcer disease in India is 9.12 per 100,000 people has ranked India #26 in the world. Such fact states the high incidence rate of peptic ulcer disease which has widened the scope for the growth of the peptic ulcer testing market in Asia Pacific.
The report includes detailed market overview, market determinants, company profiling, sector analysis, market segmentation, geographical analysis, patent analysis, strategic recommendations, key company analysis, gap analysis, key findings, market estimations, market insights, analyst insights and predictive analysis of the market.
Competitive Insights
The key players of Peptic Ulcer Testing market include Kibion AB, Beckman Coulter Inc., Biomerieux S.A., Otsuka America Pharmaceutical, Inc., Becton, Dickinson and Company, Quidel Corporation and Meridian Bioscience Inc. Merger & acquisition, product launch, strategic alliances and partnerships are the key strategies adopted by the market players. In 2015, Biomerieux launched bioNexia H. pylori Ag. test that allows the non-invasive detection of the helicobacter pylori antigen in human stool specimens. Launch of such advanced tests for the detection of h. pylori by the market players is expected to attribute significantly towards its KEY STRATEGY in the global market.
Market Segmentation
Global Peptic Ulcer Testing market is projected to witness a significant growth rate during the forecasted period 2017-2022. The growth of the market is backed by the increasing incidences of stomach cancer coupled with the changing lifestyle & food habits such as untimely meal patterns, excess consumption of fatty foods, chronic acidity and food poisoning. As per American Cancer Society, around 28,000 cases of stomach cancer is estimated to be diagnosed in the U.S. in 2017, up from 26,370 cases in 2016 and about 10,960 individuals are projected to die due to it. Such scenario has raised the need for faster as well as accurate diagnosis of peptic ulcer. The most commonly occurring stomach disease called peptic ulcer is primarily caused by sores and lesions owing to the excess secretion of the hydrochloric acid as well as pepsin enzyme from the histamine cells into the gastrointestinal tract. This disease generally occurs owing to the H. pylori (Helicobacter pylori) bacterium but can also be caused by long term usage of the non-steroidal anti-inflammatory drugs. Whereas in rare cases peptic ulcer can also occur due to presence of some specific illness or inheritance. However, only 10-15% of Helicobacter pylori positive cases develop peptic ulcers but up to 90% of all peptic ulcers occur owing to H. pylori.
In developing and underdeveloped countries, the prevalence of peptic ulcers is greater than in developed countries. This fact is further supported by the presence of high population within developing countries which is directly attributing towards the growth of the global peptic ulcer testing market. The other key factors that are driving the growth of the global market are growing usage of rapid urease test for h. pylori detection and development of advanced & new testing techniques. However, medical reimbursement issues related to certain tests in some countries is currently hampering the growth of the global peptic ulcer testing market.
Geographical Insights
Global Peptic Ulcer Testing market can be segmented geographically into Europe, North America, Asia Pacific and RoW. In 2016, Asia Pacific held the largest market in terms of rapid tests for H. pylori across the globe. Whereas in terms of revenue generation, North America leads the global peptic ulcer testing market owing to the rise in number of people suffering from peptic ulcer. In the U.S., around 5 million individuals are affected by peptic ulcer at any given time. Peptic ulcer is an important cause of the morbidity as well as healthcare costs; estimates of expenditures related to hospitalization, work loss and outpatient care (excluding medication costs) totaled around $5.65 billion per year in the U.S. Whereas, Asia Pacific is expected to witness the highest growth rate during the forecasted period. In Asia Pacific region, the incidence of peptic ulcer disease is quite high as most countries within this region are developing or under-developed and have relatively poor sanitation & hygienic condition which results in rise to contracting H. pylori infections. As per WHO, peptic ulcer disease deaths reached 85,487 in India in 2014. The age adjusted death rate due to peptic ulcer disease in India is 9.12 per 100,000 people has ranked India #26 in the world. Such fact states the high incidence rate of peptic ulcer disease which has widened the scope for the growth of the peptic ulcer testing market in Asia Pacific.
The report includes detailed market overview, market determinants, company profiling, sector analysis, market segmentation, geographical analysis, patent analysis, strategic recommendations, key company analysis, gap analysis, key findings, market estimations, market insights, analyst insights and predictive analysis of the market.
Competitive Insights
The key players of Peptic Ulcer Testing market include Kibion AB, Beckman Coulter Inc., Biomerieux S.A., Otsuka America Pharmaceutical, Inc., Becton, Dickinson and Company, Quidel Corporation and Meridian Bioscience Inc. Merger & acquisition, product launch, strategic alliances and partnerships are the key strategies adopted by the market players. In 2015, Biomerieux launched bioNexia H. pylori Ag. test that allows the non-invasive detection of the helicobacter pylori antigen in human stool specimens. Launch of such advanced tests for the detection of h. pylori by the market players is expected to attribute significantly towards its KEY STRATEGY in the global market.
Market Segmentation
- Peptic Ulcer Testing Market by Diagnostic Tests
- Upper Endoscopy
- Gastrointestinal Endoscopy
- Histology Tests
- Immunostaining Techniques
- Rapid Urease Tests
- Gastritis assessment
- Molecular Tests
- Susceptibility Testing
- Brush Cytology
- Culture Tests
- Blood Tests
- ELISA Tests
- Urea Breath Test
- Stool Tests
- Other Tests
- Peptic Ulcer Testing Market
- Hospitals
- Laboratories
- Others
- Comprehensive research methodology of global Peptic Ulcer Testing market
- In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global Peptic Ulcer Testing market
- Insights about market determinants which are stimulating the global Peptic Ulcer Testing market
- Detailed and extensive market segments with regional distribution of researched revenues
- Extensive profiles and recent developments of market players
1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
2.3. REGULATIONS
2.3.1. UNITED STATES
2.3.2. EUROPEAN UNION
2.3.3. CHINA
2.3.4. INDIA
2.3.5. REST OF THE WORLD
2.4. PATENT ANALYSIS
3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. RISING PREVALENCE OF H. PYLORI INFECTION
3.1.2. INCREASING INCIDENCES OF GASTRIC CANCER
3.1.3. GROWING USAGE OF RAPID UREASE TEST FOR H. PYLORI DETECTION
3.1.4. DEVELOPMENT OF ADVANCED AND NEW TESTING TECHNIQUES
3.1.5. CHANGING LIFESTYLE AND FOOD HABITS
3.2. RESTRAINTS
3.2.1. REIMBURSEMENT ISSUES RELATED TO CERTAIN TESTS IN SOME COUNTRIES
3.2.2. HIGH COST OF PARTICULAR TESTS
3.3. OPPORTUNITIES
3.3.1. GROWING HEALTHCARE EXPENDITURE
3.3.2. RISING AWARENESS ABOUT THE IMPORTANCE OF TIMELY DIAGNOSIS OF STOMACH ULCERS
3.3.3. ENHANCING HEALTHCARE INFRASTRUCTURE IN DEVELOPING ECONOMIES
4. MARKET SEGMENTATION
4.1. PEPTIC ULCER TESTING MARKET BY DIAGNOSTIC TESTS
4.1.1. UPPER ENDOSCOPY
4.1.2. GASTROINTESTINAL ENDOSCOPY
4.1.2.1. HISTOLOGY TESTS
4.1.2.2. IMMUNOSTAINING TECHNIQUES
4.1.2.3. RAPID UREASE TESTS
4.1.2.4. GASTRITIS ASSESSMENT
4.1.2.5. MOLECULAR TESTS
4.1.2.6. SUSCEPTIBILITY TESTING
4.1.2.7. BRUSH CYTOLOGY
4.1.2.8. CULTURE TESTS
4.1.3. BLOOD TESTS
4.1.4. ELISA TESTS
4.1.5. UREA BREATH TEST
4.1.6. STOOL TESTS
4.1.7. OTHER TESTS
4.2. PEPTIC ULCER TESTING MARKET BY END USERS
4.2.1. HOSPITALS
4.2.2. LABORATORIES
4.2.3. OTHERS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGY ANALYSIS
5.2. KEY COMPANY ANALYSIS
6. REGIONAL ANALYSIS
6.1. NORTH AMERICA
6.1.1. UNITED STATES
6.1.2. CANADA
6.1.3. REST OF NORTH AMERICA
6.2. EUROPE
6.2.1. UNITED KINGDOM
6.2.2. FRANCE
6.2.3. GERMANY
6.2.4. ITALY
6.2.5. SPAIN
6.2.6. REST OF EUROPE
6.3. ASIA PACIFIC
6.3.1. INDIA
6.3.2. CHINA
6.3.3. JAPAN
6.3.4. REST OF ASIA PACIFIC
6.4. REST OF THE WORLD
7. COMPANY PROFILES
7.1. BECTON, DICKINSON AND COMPANY
7.1.1. INTRODUCTION
7.1.2. BECTON, DICKINSON AND COMPANY PRODUCT PORTFOLIO
7.1.3. BECTON, DICKINSON AND COMPANY RECENT ACTIVITIES
7.2. BECKMAN COULTER INC.
7.2.1. INTRODUCTION
7.2.2. BECKMAN COULTER INC. PRODUCT PORTFOLIO
7.2.3. BECKMAN COULTER INC. RECENT ACTIVITIES
7.3. BIOMERIEUX S.A.
7.3.1. INTRODUCTION
7.3.2. BIOMERIEUX S.A. PRODUCT PORTFOLIO
7.3.3. BIOMERIEUX S.A. RECENT ACTIVITIES
7.4. BIOMERICA, INC.
7.4.1. INTRODUCTION
7.4.2. BIOMERICA, INC. PRODUCT PORTFOLIO
7.4.3. BIOMERICA, INC. RECENT ACTIVITIES
7.5. BIOHIT OYJ
7.5.1. INTRODUCTION
7.5.2. BIOHIT OYJ PRODUCT PORTFOLIO
7.5.3. BIOHIT OYJ RECENT ACTIVITIES
7.6. BIO-RAD LABORATORIES, INC.
7.6.1. INTRODUCTION
7.6.2. BIO-RAD LABORATORIES, INC. PRODUCT PORTFOLIO
7.6.3. BIO-RAD LABORATORIES, INC. RECENT ACTIVITIES
7.7. DIASORIN S.P.A.
7.7.1. INTRODUCTION
7.7.2. DIASORIN S.P.A. PRODUCT PORTFOLIO
7.7.3. DIASORIN S.P.A. RECENT ACTIVITIES
7.8. EKF DIAGNOSTICS
7.8.1. INTRODUCTION
7.8.2. EKF DIAGNOSTICS PRODUCT PORTFOLIO
7.8.3. EKF DIAGNOSTICS RECENT ACTIVITIES
7.9. EXALENZ BIOSCIENCE LTD.
7.9.1. INTRODUCTION
7.9.2. EXALENZ BIOSCIENCE LTD. PRODUCT PORTFOLIO
7.9.3. EXALENZ BIOSCIENCE LTD. RECENT ACTIVITIES
7.10. HALYARD HEALTH INC.
7.10.1. INTRODUCTION
7.10.2. HALYARD HEALTH INC. PRODUCT PORTFOLIO
7.10.3. HALYARD HEALTH INC. RECENT ACTIVITIES
7.11. KIBION AB
7.11.1. INTRODUCTION
7.11.2. KIBION AB PRODUCT PORTFOLIO
7.11.3. KIBION AB RECENT ACTIVITIES
7.12. MERIDIAN BIOSCIENCE INC.
7.12.1. INTRODUCTION
7.12.2. MERIDIAN BIOSCIENCE INC. PRODUCT PORTFOLIO
7.12.3. MERIDIAN BIOSCIENCE INC. RECENT ACTIVITIES
7.13. OTSUKA AMERICA PHARMACEUTICAL, INC.
7.13.1. INTRODUCTION
7.13.2. OTSUKA AMERICA PHARMACEUTICAL, INC. PRODUCT PORTFOLIO
7.13.3. OTSUKA AMERICA PHARMACEUTICAL, INC. RECENT ACTIVITIES
7.14. ORION DIAGNOSTICA OY
7.14.1. INTRODUCTION
7.14.2. ORION DIAGNOSTICA OY PRODUCT PORTFOLIO
7.14.3. ORION DIAGNOSTICA OY RECENT ACTIVITIES
7.15. POLYMEDCO CDP,LLC
7.15.1. INTRODUCTION
7.15.2. POLYMEDCO CDP,LLC PRODUCT PORTFOLIO
7.15.3. POLYMEDCO CDP,LLC RECENT ACTIVITIES
7.16. QUIDEL CORPORATION
7.16.1. INTRODUCTION
7.16.2. QUIDEL CORPORATION PRODUCT PORTFOLIO
7.16.3. QUIDEL CORPORATION RECENT ACTIVITIES
7.17. SEKISUI DIAGNOSTICS, LLC
7.17.1. INTRODUCTION
7.17.2. SEKISUI DIAGNOSTICS, LLC PRODUCT PORTFOLIO
7.17.3. SEKISUI DIAGNOSTICS, LLC RECENT ACTIVITIES
7.18. THERMO FISHER SCIENTIFIC, INC.
7.18.1. INTRODUCTION
7.18.2. THERMO FISHER SCIENTIFIC, INC. PRODUCT PORTFOLIO
7.18.3. THERMO FISHER SCIENTIFIC, INC. RECENT ACTIVITIES
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
2.3. REGULATIONS
2.3.1. UNITED STATES
2.3.2. EUROPEAN UNION
2.3.3. CHINA
2.3.4. INDIA
2.3.5. REST OF THE WORLD
2.4. PATENT ANALYSIS
3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. RISING PREVALENCE OF H. PYLORI INFECTION
3.1.2. INCREASING INCIDENCES OF GASTRIC CANCER
3.1.3. GROWING USAGE OF RAPID UREASE TEST FOR H. PYLORI DETECTION
3.1.4. DEVELOPMENT OF ADVANCED AND NEW TESTING TECHNIQUES
3.1.5. CHANGING LIFESTYLE AND FOOD HABITS
3.2. RESTRAINTS
3.2.1. REIMBURSEMENT ISSUES RELATED TO CERTAIN TESTS IN SOME COUNTRIES
3.2.2. HIGH COST OF PARTICULAR TESTS
3.3. OPPORTUNITIES
3.3.1. GROWING HEALTHCARE EXPENDITURE
3.3.2. RISING AWARENESS ABOUT THE IMPORTANCE OF TIMELY DIAGNOSIS OF STOMACH ULCERS
3.3.3. ENHANCING HEALTHCARE INFRASTRUCTURE IN DEVELOPING ECONOMIES
4. MARKET SEGMENTATION
4.1. PEPTIC ULCER TESTING MARKET BY DIAGNOSTIC TESTS
4.1.1. UPPER ENDOSCOPY
4.1.2. GASTROINTESTINAL ENDOSCOPY
4.1.2.1. HISTOLOGY TESTS
4.1.2.2. IMMUNOSTAINING TECHNIQUES
4.1.2.3. RAPID UREASE TESTS
4.1.2.4. GASTRITIS ASSESSMENT
4.1.2.5. MOLECULAR TESTS
4.1.2.6. SUSCEPTIBILITY TESTING
4.1.2.7. BRUSH CYTOLOGY
4.1.2.8. CULTURE TESTS
4.1.3. BLOOD TESTS
4.1.4. ELISA TESTS
4.1.5. UREA BREATH TEST
4.1.6. STOOL TESTS
4.1.7. OTHER TESTS
4.2. PEPTIC ULCER TESTING MARKET BY END USERS
4.2.1. HOSPITALS
4.2.2. LABORATORIES
4.2.3. OTHERS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGY ANALYSIS
5.2. KEY COMPANY ANALYSIS
6. REGIONAL ANALYSIS
6.1. NORTH AMERICA
6.1.1. UNITED STATES
6.1.2. CANADA
6.1.3. REST OF NORTH AMERICA
6.2. EUROPE
6.2.1. UNITED KINGDOM
6.2.2. FRANCE
6.2.3. GERMANY
6.2.4. ITALY
6.2.5. SPAIN
6.2.6. REST OF EUROPE
6.3. ASIA PACIFIC
6.3.1. INDIA
6.3.2. CHINA
6.3.3. JAPAN
6.3.4. REST OF ASIA PACIFIC
6.4. REST OF THE WORLD
7. COMPANY PROFILES
7.1. BECTON, DICKINSON AND COMPANY
7.1.1. INTRODUCTION
7.1.2. BECTON, DICKINSON AND COMPANY PRODUCT PORTFOLIO
7.1.3. BECTON, DICKINSON AND COMPANY RECENT ACTIVITIES
7.2. BECKMAN COULTER INC.
7.2.1. INTRODUCTION
7.2.2. BECKMAN COULTER INC. PRODUCT PORTFOLIO
7.2.3. BECKMAN COULTER INC. RECENT ACTIVITIES
7.3. BIOMERIEUX S.A.
7.3.1. INTRODUCTION
7.3.2. BIOMERIEUX S.A. PRODUCT PORTFOLIO
7.3.3. BIOMERIEUX S.A. RECENT ACTIVITIES
7.4. BIOMERICA, INC.
7.4.1. INTRODUCTION
7.4.2. BIOMERICA, INC. PRODUCT PORTFOLIO
7.4.3. BIOMERICA, INC. RECENT ACTIVITIES
7.5. BIOHIT OYJ
7.5.1. INTRODUCTION
7.5.2. BIOHIT OYJ PRODUCT PORTFOLIO
7.5.3. BIOHIT OYJ RECENT ACTIVITIES
7.6. BIO-RAD LABORATORIES, INC.
7.6.1. INTRODUCTION
7.6.2. BIO-RAD LABORATORIES, INC. PRODUCT PORTFOLIO
7.6.3. BIO-RAD LABORATORIES, INC. RECENT ACTIVITIES
7.7. DIASORIN S.P.A.
7.7.1. INTRODUCTION
7.7.2. DIASORIN S.P.A. PRODUCT PORTFOLIO
7.7.3. DIASORIN S.P.A. RECENT ACTIVITIES
7.8. EKF DIAGNOSTICS
7.8.1. INTRODUCTION
7.8.2. EKF DIAGNOSTICS PRODUCT PORTFOLIO
7.8.3. EKF DIAGNOSTICS RECENT ACTIVITIES
7.9. EXALENZ BIOSCIENCE LTD.
7.9.1. INTRODUCTION
7.9.2. EXALENZ BIOSCIENCE LTD. PRODUCT PORTFOLIO
7.9.3. EXALENZ BIOSCIENCE LTD. RECENT ACTIVITIES
7.10. HALYARD HEALTH INC.
7.10.1. INTRODUCTION
7.10.2. HALYARD HEALTH INC. PRODUCT PORTFOLIO
7.10.3. HALYARD HEALTH INC. RECENT ACTIVITIES
7.11. KIBION AB
7.11.1. INTRODUCTION
7.11.2. KIBION AB PRODUCT PORTFOLIO
7.11.3. KIBION AB RECENT ACTIVITIES
7.12. MERIDIAN BIOSCIENCE INC.
7.12.1. INTRODUCTION
7.12.2. MERIDIAN BIOSCIENCE INC. PRODUCT PORTFOLIO
7.12.3. MERIDIAN BIOSCIENCE INC. RECENT ACTIVITIES
7.13. OTSUKA AMERICA PHARMACEUTICAL, INC.
7.13.1. INTRODUCTION
7.13.2. OTSUKA AMERICA PHARMACEUTICAL, INC. PRODUCT PORTFOLIO
7.13.3. OTSUKA AMERICA PHARMACEUTICAL, INC. RECENT ACTIVITIES
7.14. ORION DIAGNOSTICA OY
7.14.1. INTRODUCTION
7.14.2. ORION DIAGNOSTICA OY PRODUCT PORTFOLIO
7.14.3. ORION DIAGNOSTICA OY RECENT ACTIVITIES
7.15. POLYMEDCO CDP,LLC
7.15.1. INTRODUCTION
7.15.2. POLYMEDCO CDP,LLC PRODUCT PORTFOLIO
7.15.3. POLYMEDCO CDP,LLC RECENT ACTIVITIES
7.16. QUIDEL CORPORATION
7.16.1. INTRODUCTION
7.16.2. QUIDEL CORPORATION PRODUCT PORTFOLIO
7.16.3. QUIDEL CORPORATION RECENT ACTIVITIES
7.17. SEKISUI DIAGNOSTICS, LLC
7.17.1. INTRODUCTION
7.17.2. SEKISUI DIAGNOSTICS, LLC PRODUCT PORTFOLIO
7.17.3. SEKISUI DIAGNOSTICS, LLC RECENT ACTIVITIES
7.18. THERMO FISHER SCIENTIFIC, INC.
7.18.1. INTRODUCTION
7.18.2. THERMO FISHER SCIENTIFIC, INC. PRODUCT PORTFOLIO
7.18.3. THERMO FISHER SCIENTIFIC, INC. RECENT ACTIVITIES
LIST OF TABLES
Table # 1 GLOBAL PEPTIC ULCER TESTING MARKET RESEARCH AND ANALYSIS, BY DIAGNOSTIC TESTS 2015-2022 ($ MILLION)
Table # 2 GLOBAL UPPER ENDOSCOPY MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 3 GLOBAL GASTROINTESTINAL ENDOSCOPY RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 4 GLOBAL HISTOLOGY TESTS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 5 GLOBAL IMMUNOSTAINING TECHNIQUES MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 6 GLOBAL RAPID UREASE TESTS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 7 GLOBAL GASTRITIS ASSESSMENT MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 8 GLOBAL MOLECULAR TESTS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 9 GLOBAL SUSCEPTIBILITY TESTING MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 10 GLOBAL BRUSH CYTOLOGY MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 11 GLOBAL CULTURE TESTS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 12 GLOBAL BLOOD TESTS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 13 GLOBAL ELISA TESTS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 14 GLOBAL UREA BREATH TESTS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 15 GLOBAL STOOL TESTS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 16 GLOBAL OTHER TESTS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 17 GLOBAL PEPTIC ULCER TESTING MARKET RESEARCH AND ANALYSIS, BY END USERS 2015-2022 ($ MILLION)
Table # 18 GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 19 GLOBAL LABORATORIES MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 20 GLOBAL OTHER END USERS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 21 BECTON, DICKINSON AND COMPANY PRODUCT PORTFOLIO
Table # 22 BECTON, DICKINSON AND COMPANY RECENT ACTIVITIES
Table # 23 BECKMAN COULTER INC. PRODUCT PORTFOLIO
Table # 24 BECKMAN COULTER INC. RECENT ACTIVITIES
Table # 25 BIOMERIEUX S.A. PRODUCT PORTFOLIO
Table # 26 BIOMERIEUX S.A. RECENT ACTIVITIES
Table # 27 BIOMERICA, INC. PRODUCT PORTFOLIO
Table # 28 BIOMERICA, INC. RECENT ACTIVITIES
Table # 29 BIOHIT OYJ PRODUCT PORTFOLIO
Table # 30 BIOHIT OYJ RECENT ACTIVITIES
Table # 31 BIO-RAD LABORATORIES, INC. PRODUCT PORTFOLIO
Table # 32 BIO-RAD LABORATORIES, INC. RECENT ACTIVITIES
Table # 33 DIASORIN S.P.A. PRODUCT PORTFOLIO
Table # 34 DIASORIN S.P.A. RECENT ACTIVITIES
Table # 35 EKF DIAGNOSTICS PRODUCT PORTFOLIO
Table # 36 EKF DIAGNOSTICS RECENT ACTIVITIES
Table # 37 EXALENZ BIOSCIENCE LTD. PRODUCT PORTFOLIO
Table # 38 EXALENZ BIOSCIENCE LTD. RECENT ACTIVITIES
Table # 39 HALYARD HEALTH INC. PRODUCT PORTFOLIO
Table # 40 HALYARD HEALTH INC. RECENT ACTIVITIES
Table # 41 KIBION AB PRODUCT PORTFOLIO
Table # 42 KIBION AB RECENT ACTIVITIES
Table # 43 MERIDIAN BIOSCIENCE INC. PRODUCT PORTFOLIO
Table # 44 MERIDIAN BIOSCIENCE INC. RECENT ACTIVITIES
Table # 45 OTSUKA AMERICA PHARMACEUTICAL, INC. PRODUCT PORTFOLIO
Table # 46 OTSUKA AMERICA PHARMACEUTICAL, INC. RECENT ACTIVITIES
Table # 47 ORION DIAGNOSTICA OY PRODUCT PORTFOLIO
Table # 48 ORION DIAGNOSTICA OY RECENT ACTIVITIES
Table # 49 POLYMEDCO CDP,LLC PRODUCT PORTFOLIO
Table # 50 POLYMEDCO CDP,LLC RECENT ACTIVITIES
Table # 51 QUIDEL CORPORATION PRODUCT PORTFOLIO
Table # 52 QUIDEL CORPORATION RECENT ACTIVITIES
Table # 53 SEKISUI DIAGNOSTICS, LLC PRODUCT PORTFOLIO
Table # 54 SEKISUI DIAGNOSTICS, LLC RECENT ACTIVITIES
Table # 55 THERMO FISHER SCIENTIFIC, INC. PRODUCT PORTFOLIO
Table # 56 THERMO FISHER SCIENTIFIC, INC. RECENT ACTIVITIES
Table # 1 GLOBAL PEPTIC ULCER TESTING MARKET RESEARCH AND ANALYSIS, BY DIAGNOSTIC TESTS 2015-2022 ($ MILLION)
Table # 2 GLOBAL UPPER ENDOSCOPY MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 3 GLOBAL GASTROINTESTINAL ENDOSCOPY RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 4 GLOBAL HISTOLOGY TESTS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 5 GLOBAL IMMUNOSTAINING TECHNIQUES MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 6 GLOBAL RAPID UREASE TESTS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 7 GLOBAL GASTRITIS ASSESSMENT MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 8 GLOBAL MOLECULAR TESTS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 9 GLOBAL SUSCEPTIBILITY TESTING MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 10 GLOBAL BRUSH CYTOLOGY MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 11 GLOBAL CULTURE TESTS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 12 GLOBAL BLOOD TESTS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 13 GLOBAL ELISA TESTS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 14 GLOBAL UREA BREATH TESTS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 15 GLOBAL STOOL TESTS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 16 GLOBAL OTHER TESTS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 17 GLOBAL PEPTIC ULCER TESTING MARKET RESEARCH AND ANALYSIS, BY END USERS 2015-2022 ($ MILLION)
Table # 18 GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 19 GLOBAL LABORATORIES MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 20 GLOBAL OTHER END USERS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table # 21 BECTON, DICKINSON AND COMPANY PRODUCT PORTFOLIO
Table # 22 BECTON, DICKINSON AND COMPANY RECENT ACTIVITIES
Table # 23 BECKMAN COULTER INC. PRODUCT PORTFOLIO
Table # 24 BECKMAN COULTER INC. RECENT ACTIVITIES
Table # 25 BIOMERIEUX S.A. PRODUCT PORTFOLIO
Table # 26 BIOMERIEUX S.A. RECENT ACTIVITIES
Table # 27 BIOMERICA, INC. PRODUCT PORTFOLIO
Table # 28 BIOMERICA, INC. RECENT ACTIVITIES
Table # 29 BIOHIT OYJ PRODUCT PORTFOLIO
Table # 30 BIOHIT OYJ RECENT ACTIVITIES
Table # 31 BIO-RAD LABORATORIES, INC. PRODUCT PORTFOLIO
Table # 32 BIO-RAD LABORATORIES, INC. RECENT ACTIVITIES
Table # 33 DIASORIN S.P.A. PRODUCT PORTFOLIO
Table # 34 DIASORIN S.P.A. RECENT ACTIVITIES
Table # 35 EKF DIAGNOSTICS PRODUCT PORTFOLIO
Table # 36 EKF DIAGNOSTICS RECENT ACTIVITIES
Table # 37 EXALENZ BIOSCIENCE LTD. PRODUCT PORTFOLIO
Table # 38 EXALENZ BIOSCIENCE LTD. RECENT ACTIVITIES
Table # 39 HALYARD HEALTH INC. PRODUCT PORTFOLIO
Table # 40 HALYARD HEALTH INC. RECENT ACTIVITIES
Table # 41 KIBION AB PRODUCT PORTFOLIO
Table # 42 KIBION AB RECENT ACTIVITIES
Table # 43 MERIDIAN BIOSCIENCE INC. PRODUCT PORTFOLIO
Table # 44 MERIDIAN BIOSCIENCE INC. RECENT ACTIVITIES
Table # 45 OTSUKA AMERICA PHARMACEUTICAL, INC. PRODUCT PORTFOLIO
Table # 46 OTSUKA AMERICA PHARMACEUTICAL, INC. RECENT ACTIVITIES
Table # 47 ORION DIAGNOSTICA OY PRODUCT PORTFOLIO
Table # 48 ORION DIAGNOSTICA OY RECENT ACTIVITIES
Table # 49 POLYMEDCO CDP,LLC PRODUCT PORTFOLIO
Table # 50 POLYMEDCO CDP,LLC RECENT ACTIVITIES
Table # 51 QUIDEL CORPORATION PRODUCT PORTFOLIO
Table # 52 QUIDEL CORPORATION RECENT ACTIVITIES
Table # 53 SEKISUI DIAGNOSTICS, LLC PRODUCT PORTFOLIO
Table # 54 SEKISUI DIAGNOSTICS, LLC RECENT ACTIVITIES
Table # 55 THERMO FISHER SCIENTIFIC, INC. PRODUCT PORTFOLIO
Table # 56 THERMO FISHER SCIENTIFIC, INC. RECENT ACTIVITIES
LIST OF FIGURES
Figure # 1 NORTH AMERICA MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 2 US MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 3 CANADA MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 5 UK MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 6 FRANCE MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 7 GERMANY MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 8 ITALY MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 9 SPAIN MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 10 ROE MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 11 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 12 INDIA MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 13 CHINA MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 14 JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 15 ROAPAC MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 16 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 1 NORTH AMERICA MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 2 US MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 3 CANADA MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 5 UK MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 6 FRANCE MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 7 GERMANY MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 8 ITALY MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 9 SPAIN MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 10 ROE MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 11 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 12 INDIA MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 13 CHINA MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 14 JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 15 ROAPAC MARKET RESEARCH AND ANALYSIS, 2015-2022
Figure # 16 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2022
